Developing breakthrough oncology drug candidates
Our research & development
Read more
Don't miss any news, subscribe on our press releases.
Subscribe to our newsletter
We are driven by Making a difference for those affected by cancer
Sprint Bioscience is a pharmaceutical company focused on developing innovative drug candidates that can contribute to new treatments for cancer. The great need for new treatments for difficult-to-treat cancer brings great commercial potential.
Using a fragment-based drug development approach, we develop drug programs in a time- and resource-efficient manner that are out-licensed to global pharmaceutical companies during the preclinical phase.
Press releases
Show all